NCT00760448View on ClinicalTrials.gov

Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia

PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin detemir

DRUG

insulin NPH

Trial Locations (1)

GU2 7XX

Novo Nordisk Investigational Site, Guildford

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT00760448 - Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia | Biotech Hunter | Biotech Hunter